PMC5613267_01
Pretreatment ultrasonographic findings.
NCI-4-180-g001.jpg
PMC5613267_01_NCI-4-180-g001.jpg
F1
US was performed and revealed a 31.1x20.4x14.2 mm hypoechoic mass, which was evaluated as consistent with organized, residual hematoma (Figure 1). Since hemoglobin level and hemodynamic data of the patient were stable and there was no life-threatening bleeding, his oral anticoagulant treatment was not discontinued. US therapy was thought to be a potential treatment for hematoma resorption.
Posttreatment ultrasonographic findings.
NCI-4-180-g002.jpg
PMC5613267_01_NCI-4-180-g002.jpg
F2
Treatment site was determined based on US findings of heterogeneous isoechoic mass (30.8x11.3x8.3 mm) surrounded by calcific hyperechoic images (Figure 2).